TXN and cancer: TXNRD1 is an activator of thioredoxin, an oxidoreductase targeting cysteine residue of cellular proteins, including redox-sensitive transcription factors, such as NF-κB and p53, playing a critical role in cancer cells and that needs a reducing environment for their DNA binding efficacy [57].